Shockwave Medical Inc (SWAV)
330.38
+0.38
(+0.12%)
USD |
NASDAQ |
May 03, 16:00
330.38
0.00 (0.00%)
After-Hours: 20:00
Shockwave Medical Research and Development Expense (Annual): 145.65M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 145.65M |
| December 31, 2022 | 81.68M |
| December 31, 2021 | 50.54M |
| December 31, 2020 | 36.93M |
| Date | Value |
|---|---|
| December 31, 2019 | 32.85M |
| December 31, 2018 | 22.70M |
| December 31, 2017 | 17.96M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
32.85M
Minimum
2019
145.65M
Maximum
2023
69.53M
Average
50.54M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| AtriCure Inc | 73.92M |
| Masimo Corp | 175.20M |
| Perspective Therapeutics Inc | 21.31M |
| Xtant Medical Holdings Inc | 1.336M |